tiprankstipranks
Trending News
More News >
Iovance Biotherapeutics Inc (DE:2LB)
FRANKFURT:2LB
Germany Market

Iovance Biotherapeutics (2LB) Cash flow

Compare
17 Followers

Iovance Biotherapeutics Cash Flow

DE:2LB's free cash flow for Q4 2025 was $-61.88M. For the 2025 fiscal year, DE:2LB's free cash flow was decreased by $27.80M and operating cash flow was $-52.56M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -302.41M$ -352.98M$ -361.82M$ -292.76M$ -227.94M
Investing Cash Flow
$ 47.50M$ -96.41M$ -155.24M$ 256.45M$ 132.00K
Financing Cash Flow
$ 300.77M$ 390.66M$ 462.96M$ 190.15M$ 239.27M
End Cash Position
$ 169.06M$ 122.05M$ 181.32M$ 238.16M$ 84.31M
Free Cash Flow
$ -336.24M$ -364.05M$ -384.11M$ -313.18M$ -265.51M
Currency in USD

Iovance Biotherapeutics Cash Flow